Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Tese |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=4629857 https://repositorio.unifesp.br/handle/11600/46883 |
Resumo: | Post-menopausal women commonly present obesity, metabolic disorders and psychiatric disturbances, which lead to a loss of life quality. Although hormone replacement therapy (HRT) ameliorates some of these symptoms, there is a higher risk for developing cardiovascular diseases and breast cancer. Thus, finding alternative therapies with minimal side effects for management of menopause-related alterations is highly desirable. We have demonstrated that Ginkgo biloba extract (GbE) reduced visceral adiposity, softened the inflammatory status in retroperitoneal adipose tissue and improved peripheral insulin sensitivity in diet-induced obese rats. The present research aimed to study, in ovariectomized rats, whether a prolonged therapy with GbE ameliorates obesity and behavioral alterations associated to ovarian hormones absence, emphasizing hypothalamic serotonin activity. 2-mo-old rats were underwent to ovariectomy (OVX) or false-ovariectomy (Sham). After surgery, body weight and food intake were measured weekly. At 4-mo-old, the rats were divided into 4 groups: Sham, Sham+GbE, OVX and OVX+GbE. The phytotherapy therapy was carried out for 14 days. The Sham+ GbE and OVX+GbE group received a daily dose of GbE (500mg/kg) diluted in 0.9% saline (vehicle) while the Sham and OVX rats received only the vehicle. During the phytotherapy treatment, body weight and food intake were measured daily. The rats were submitted to the Elevated Plus Maze and Forced Swim Tests to evaluate anxiety and depressive-like behaviors. A subset of animals received both an intracerebroventricular injection (i.c.v., lateral ventricle) of vehicle or 300g serotonin and food intake was measured 12 hours and 24 hours after each injection. In another subset of rats, a guide cannula was steriotaxically implanted in the ventromedial hypothalamus, whereby a microdialysis probe was introduced and extracellular levels of 5-HT was measured by HPLC with electrochemical detection. We evaluated the protein expression of hypothalamic serotonergic receptors 5-HT1A, 5-HT1B and 5-HT2C, the serotonin transporter (5-HTT) and the anorectic mediator POMC. Additionally, we assessed: body fat, carcass protein content, amount of liver lipids, lipid profile, alanine and aspartate aminotransferase activity (ALT/AST), serum fasting glucose, insulin, leptin, adiponectin and tumor necrosis factor-α (TNF-α) at the end of treatment. A model of Multiple Linear Regression was applied to explain anxiety and depressive-like behaviors adopting body composition measurements and serum parameters as independent variables.The OVX group showed such anxious and depressive behaviors, and it does not respond to the anorectic action of serotonin. Moreover, ovariectomy provided an excessive body mass and visceral adiposity, hyperleptinemia and dyslipidemia, characterized by an increase in total cholesterol and LDL-cholesterol. During the phytotherapy therapy, GbE promoted hypophagic effect in the OVX+GbE group, reduced symptoms of anxiety and depression and restore the effectiveness of serotonin anorectic response. On the medial hypothalamus, GbE increased extracellular serotonin levels in the OVX+GbE group. Among the metabolic effects, GbE decreased the visceral fat, increased protein carcass content, stimulated adiponectin levels, improved lipid profile and decreased the amount of liver lipids of OVX+GbE rats. Multiple linear regressions found that insulin was a predictor of anxiety in Sham rats, while treatment with GbE removed this relationship. In OVX rats, HOMA- presented an anxiolytic effect. Lower body fat and higher HDL-cholesterol levels were considered predictors for anxiolytic behavior of OVX+GbE rats. Regarding depressive-like behaviors, visceral adiposity was pointed as the most determining factor, but this relationship was not observed in the OVX+GbE rats. The phytotherapy treatment for 14 days reduced either anxious and depressed symptoms, provided a healthier body composition, improved lipid profile, enhanced extracellular levels of serotonin in the medial hypothalamus and restored the anorectic response to serotonin. Taking together all these benefic effects, it is possible that GbE might be an effective and alternative therapy for the management of menopause-related symptoms. |
id |
UFSP_b3f75053bbc6c9bed30dfb7029dc3044 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/46883 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadasEffect of the treatment with a Ginkgo biloba standardized extract on the hypothalamic serotonergic signaling of ovariectomized ratsGinkgo bilobaOvariectomizedHypothalamicSerotonergicOvariectomiaSerotoninaControle central da ingestão alimentarGinkgo bilobaHipotálamoPost-menopausal women commonly present obesity, metabolic disorders and psychiatric disturbances, which lead to a loss of life quality. Although hormone replacement therapy (HRT) ameliorates some of these symptoms, there is a higher risk for developing cardiovascular diseases and breast cancer. Thus, finding alternative therapies with minimal side effects for management of menopause-related alterations is highly desirable. We have demonstrated that Ginkgo biloba extract (GbE) reduced visceral adiposity, softened the inflammatory status in retroperitoneal adipose tissue and improved peripheral insulin sensitivity in diet-induced obese rats. The present research aimed to study, in ovariectomized rats, whether a prolonged therapy with GbE ameliorates obesity and behavioral alterations associated to ovarian hormones absence, emphasizing hypothalamic serotonin activity. 2-mo-old rats were underwent to ovariectomy (OVX) or false-ovariectomy (Sham). After surgery, body weight and food intake were measured weekly. At 4-mo-old, the rats were divided into 4 groups: Sham, Sham+GbE, OVX and OVX+GbE. The phytotherapy therapy was carried out for 14 days. The Sham+ GbE and OVX+GbE group received a daily dose of GbE (500mg/kg) diluted in 0.9% saline (vehicle) while the Sham and OVX rats received only the vehicle. During the phytotherapy treatment, body weight and food intake were measured daily. The rats were submitted to the Elevated Plus Maze and Forced Swim Tests to evaluate anxiety and depressive-like behaviors. A subset of animals received both an intracerebroventricular injection (i.c.v., lateral ventricle) of vehicle or 300g serotonin and food intake was measured 12 hours and 24 hours after each injection. In another subset of rats, a guide cannula was steriotaxically implanted in the ventromedial hypothalamus, whereby a microdialysis probe was introduced and extracellular levels of 5-HT was measured by HPLC with electrochemical detection. We evaluated the protein expression of hypothalamic serotonergic receptors 5-HT1A, 5-HT1B and 5-HT2C, the serotonin transporter (5-HTT) and the anorectic mediator POMC. Additionally, we assessed: body fat, carcass protein content, amount of liver lipids, lipid profile, alanine and aspartate aminotransferase activity (ALT/AST), serum fasting glucose, insulin, leptin, adiponectin and tumor necrosis factor-α (TNF-α) at the end of treatment. A model of Multiple Linear Regression was applied to explain anxiety and depressive-like behaviors adopting body composition measurements and serum parameters as independent variables.The OVX group showed such anxious and depressive behaviors, and it does not respond to the anorectic action of serotonin. Moreover, ovariectomy provided an excessive body mass and visceral adiposity, hyperleptinemia and dyslipidemia, characterized by an increase in total cholesterol and LDL-cholesterol. During the phytotherapy therapy, GbE promoted hypophagic effect in the OVX+GbE group, reduced symptoms of anxiety and depression and restore the effectiveness of serotonin anorectic response. On the medial hypothalamus, GbE increased extracellular serotonin levels in the OVX+GbE group. Among the metabolic effects, GbE decreased the visceral fat, increased protein carcass content, stimulated adiponectin levels, improved lipid profile and decreased the amount of liver lipids of OVX+GbE rats. Multiple linear regressions found that insulin was a predictor of anxiety in Sham rats, while treatment with GbE removed this relationship. In OVX rats, HOMA- presented an anxiolytic effect. Lower body fat and higher HDL-cholesterol levels were considered predictors for anxiolytic behavior of OVX+GbE rats. Regarding depressive-like behaviors, visceral adiposity was pointed as the most determining factor, but this relationship was not observed in the OVX+GbE rats. The phytotherapy treatment for 14 days reduced either anxious and depressed symptoms, provided a healthier body composition, improved lipid profile, enhanced extracellular levels of serotonin in the medial hypothalamus and restored the anorectic response to serotonin. Taking together all these benefic effects, it is possible that GbE might be an effective and alternative therapy for the management of menopause-related symptoms.Mulheres na pós-menopausa comumente sofrem de obesidade, distúrbios metabólicos e desordens psiquiátricas, o que acarreta em prejuízo da qualidade de vida. Embora a terapia de reposição hormonal (TRH) amenize alguns desses sintomas, há um risco maior de desenvolvimento de doenças cardiovasculares e câncer de mama. Dessa forma, encontrar terapias alternativas e com o mínimo de efeitos colaterais no manejo das alterações associadas à menopausa é de suma importância. Já demonstramos que o extrato de Ginkgo biloba (EGb) reduziu a adiposidade visceral, amenizou o estado inflamatório no tecido adiposo retroperitoneal e melhorou a sensibilidade periférica à insulina em ratos com obesidade induzida por dieta hiperlipídica. O objetivo do presente estudo foi investigar, em ratas ovariectomizadas com 120 dias de idade, se o tratamento com extrato padronizado de Ginkgo biloba atenua as alterações relacionadas à falta de hormônios ovarianos em relação ao desenvolvimento de obesidade e comportamentos de tipo depressivo e ansioso, com ênfase na atividade serotoninérgica hipotalâmica. Ratas de 2 meses de idade foram submetidas à ovariectomia (OVX) ou falsa ovariectomia (Sham). Após a cirurgia, a massa corporal e ingestão alimentar foram avaliadas semanalmente. Aos 4 meses, as ratas foram divididas em 4 grupos: Sham, Sham+GbE, OVX e OVX+GbE. O tratamento fitoterápico foi realizado durante 14 dias. As ratas Sham+GbE e OVX+GbE receberam uma dose diária de EGb (500mg/Kg) diluída em salina 0,9% (veículo) enquanto as ratas Sham e OVX receberam apenas o veículo. Durante o tratamento, a massa corporal e ingestão alimentar foram medidas diariamente. As ratas foram submetidas aos testes do Labirinto em Cruz Elevado e Nado Forçado para avaliação de comportamento do tipo ansioso e depressivo. Um subconjunto de animais recebeu ambas injeções intracerebroventriculares (i.c.v., ventrículo lateral) de veículo e/ou 300?g de serotonina e a ingestão alimentar foi mensurada 12h e 24h após cada injeção. Em outro subconjunto de ratas, uma cânula-guia foi implantada esteriotaxicamente no hipotálamo ventromedial direito, através da qual um probe de microdiálise foi introduzido e os níveis extracelulares de 5-HT foram medidos por HPLC com detecção eletroquímica. Foi avaliada a expressão protéica hipotalâmica dos receptores serotoninérgicos 5-HT1A, 5-HT1B e 5-HT2C, do transportador de serotonina (5-HTT) e do mediador anorexígeno POMC. Adicionalmente, foram avaliados: a adiposidade corporal, conteúdo de proteína da carcaça, quantidade de lipídeos hepáticos, perfil lipídico, atividade das enzimas hepáticas alanina e aspartato aminotransferase (ALT/AST), níveis séricos de glicose de jejum, insulina, leptina, adiponectina e fator de necrose tumoral-? (TNF-?) ao término do tratamento. Foi aplicado um modelo de Regressão Linear Múltipla para explicar comportamentos do tipo ansioso e depressivo adotando as medidas de composição corporal e parâmetros séricos como variáveis independentes. O grupo OVX apresentou comportamentos de tipo ansioso e depressivo, além de não responder à ação anorexígena da serotonina. Além disso, a ovariectomia proporcionou ganho excessivo de massa e adiposidade corporais, hiperleptinemia e dislipidemia, caracterizada pelo aumento do colesterol total e do LDL-colesterol. Durante o tratamento, o EGb reduziu a ingestão alimentar do grupo OVX+GbE, amenizou os sintomas de tipo ansioso e depressivo, além de restaurar a efetividade da resposta anorexígena da serotonina. No hipotálamo medial, o EGb aumentou os níveis extracelulares de serotonina nos animais ovariectomizados tratados com o EGb. Dentre os efeitos metabólicos, o EGb diminuiu a quantidade de tecido adiposo retroperitoneal, aumentou conteúdo protéico da carcaça, estimulou a produção de adiponectina, além de melhorar o perfil lipídico e diminuir a quantidade de lipídeos hepático das ratas OVX+GbE. O modelo de Regressão Linear Múltipla identificou que a insulinemia é preditor para sintomas de ansiedade nas ratas Sham, enquanto o tratamento com EGb retirou essa relação. Nas ratas OVX, o HOMA-? apresentou efeito ansiolítico. A diminuição da adiposidade corporal e aumento do HDL-colesterol foram considerados preditores importantes para o comportamento menos ansioso das ratas OVX+GbE. Em relação aos comportamentos de tipo depressivo, a adiposidade visceral foi apontada como o fator mais determinante, porém essa relação não foi observada nas ratas OVX+GbE. A terapia com EGb durante 14 dias reduziu comportamentos de tipo ansioso e depressivo, proporcionou uma composição corporal mais saudável, melhora do perfil lipídico, aumento dos níveis extracelulares de serotonina no hipotálamo medial além de restabelecer a resposta anorexígena à serotonina. Estes efeitos benéficos em conjunto subsidiam a proposição de que o EGb consiste em uma terapia alternativa e eficaz para o manejo dos sintomas relacionados à menopausa.Dados abertos - Sucupira - Teses e dissertações (2013 a 2016)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Universidade Federal de São Paulo (UNIFESP)Ribeiro, Eliane Beraldi [UNIFESP]http://lattes.cnpq.br/6518739448365292http://lattes.cnpq.br/9116883119071870Universidade Federal de São Paulo (UNIFESP)Banin, Renata Mancini [UNIFESP]2018-07-27T15:51:00Z2018-07-27T15:51:00Z2016-12-31info:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/publishedVersion146 f.application/pdfhttps://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=4629857BANIN, Renata Mancini. Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas. 2016. 146 f. Tese (Doutorado em Nutrição) - Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 2016.Renata Mancini Banin - PDF A.pdfhttps://repositorio.unifesp.br/handle/11600/46883porSão Pauloinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-09T01:48:04Zoai:repositorio.unifesp.br/:11600/46883Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-09T01:48:04Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas Effect of the treatment with a Ginkgo biloba standardized extract on the hypothalamic serotonergic signaling of ovariectomized rats |
title |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas |
spellingShingle |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas Banin, Renata Mancini [UNIFESP] Ginkgo biloba Ovariectomized Hypothalamic Serotonergic Ovariectomia Serotonina Controle central da ingestão alimentar Ginkgo biloba Hipotálamo |
title_short |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas |
title_full |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas |
title_fullStr |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas |
title_full_unstemmed |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas |
title_sort |
Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas |
author |
Banin, Renata Mancini [UNIFESP] |
author_facet |
Banin, Renata Mancini [UNIFESP] |
author_role |
author |
dc.contributor.none.fl_str_mv |
Ribeiro, Eliane Beraldi [UNIFESP] http://lattes.cnpq.br/6518739448365292 http://lattes.cnpq.br/9116883119071870 Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Banin, Renata Mancini [UNIFESP] |
dc.subject.por.fl_str_mv |
Ginkgo biloba Ovariectomized Hypothalamic Serotonergic Ovariectomia Serotonina Controle central da ingestão alimentar Ginkgo biloba Hipotálamo |
topic |
Ginkgo biloba Ovariectomized Hypothalamic Serotonergic Ovariectomia Serotonina Controle central da ingestão alimentar Ginkgo biloba Hipotálamo |
description |
Post-menopausal women commonly present obesity, metabolic disorders and psychiatric disturbances, which lead to a loss of life quality. Although hormone replacement therapy (HRT) ameliorates some of these symptoms, there is a higher risk for developing cardiovascular diseases and breast cancer. Thus, finding alternative therapies with minimal side effects for management of menopause-related alterations is highly desirable. We have demonstrated that Ginkgo biloba extract (GbE) reduced visceral adiposity, softened the inflammatory status in retroperitoneal adipose tissue and improved peripheral insulin sensitivity in diet-induced obese rats. The present research aimed to study, in ovariectomized rats, whether a prolonged therapy with GbE ameliorates obesity and behavioral alterations associated to ovarian hormones absence, emphasizing hypothalamic serotonin activity. 2-mo-old rats were underwent to ovariectomy (OVX) or false-ovariectomy (Sham). After surgery, body weight and food intake were measured weekly. At 4-mo-old, the rats were divided into 4 groups: Sham, Sham+GbE, OVX and OVX+GbE. The phytotherapy therapy was carried out for 14 days. The Sham+ GbE and OVX+GbE group received a daily dose of GbE (500mg/kg) diluted in 0.9% saline (vehicle) while the Sham and OVX rats received only the vehicle. During the phytotherapy treatment, body weight and food intake were measured daily. The rats were submitted to the Elevated Plus Maze and Forced Swim Tests to evaluate anxiety and depressive-like behaviors. A subset of animals received both an intracerebroventricular injection (i.c.v., lateral ventricle) of vehicle or 300g serotonin and food intake was measured 12 hours and 24 hours after each injection. In another subset of rats, a guide cannula was steriotaxically implanted in the ventromedial hypothalamus, whereby a microdialysis probe was introduced and extracellular levels of 5-HT was measured by HPLC with electrochemical detection. We evaluated the protein expression of hypothalamic serotonergic receptors 5-HT1A, 5-HT1B and 5-HT2C, the serotonin transporter (5-HTT) and the anorectic mediator POMC. Additionally, we assessed: body fat, carcass protein content, amount of liver lipids, lipid profile, alanine and aspartate aminotransferase activity (ALT/AST), serum fasting glucose, insulin, leptin, adiponectin and tumor necrosis factor-α (TNF-α) at the end of treatment. A model of Multiple Linear Regression was applied to explain anxiety and depressive-like behaviors adopting body composition measurements and serum parameters as independent variables.The OVX group showed such anxious and depressive behaviors, and it does not respond to the anorectic action of serotonin. Moreover, ovariectomy provided an excessive body mass and visceral adiposity, hyperleptinemia and dyslipidemia, characterized by an increase in total cholesterol and LDL-cholesterol. During the phytotherapy therapy, GbE promoted hypophagic effect in the OVX+GbE group, reduced symptoms of anxiety and depression and restore the effectiveness of serotonin anorectic response. On the medial hypothalamus, GbE increased extracellular serotonin levels in the OVX+GbE group. Among the metabolic effects, GbE decreased the visceral fat, increased protein carcass content, stimulated adiponectin levels, improved lipid profile and decreased the amount of liver lipids of OVX+GbE rats. Multiple linear regressions found that insulin was a predictor of anxiety in Sham rats, while treatment with GbE removed this relationship. In OVX rats, HOMA- presented an anxiolytic effect. Lower body fat and higher HDL-cholesterol levels were considered predictors for anxiolytic behavior of OVX+GbE rats. Regarding depressive-like behaviors, visceral adiposity was pointed as the most determining factor, but this relationship was not observed in the OVX+GbE rats. The phytotherapy treatment for 14 days reduced either anxious and depressed symptoms, provided a healthier body composition, improved lipid profile, enhanced extracellular levels of serotonin in the medial hypothalamus and restored the anorectic response to serotonin. Taking together all these benefic effects, it is possible that GbE might be an effective and alternative therapy for the management of menopause-related symptoms. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12-31 2018-07-27T15:51:00Z 2018-07-27T15:51:00Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
doctoralThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=4629857 BANIN, Renata Mancini. Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas. 2016. 146 f. Tese (Doutorado em Nutrição) - Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 2016. Renata Mancini Banin - PDF A.pdf https://repositorio.unifesp.br/handle/11600/46883 |
url |
https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=4629857 https://repositorio.unifesp.br/handle/11600/46883 |
identifier_str_mv |
BANIN, Renata Mancini. Efeito do tratamento com extrato padronizado de Ginkgo Biloba sobre a sinalização serotoninérgica hipotalâmica de ratas ovariectomizadas. 2016. 146 f. Tese (Doutorado em Nutrição) - Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 2016. Renata Mancini Banin - PDF A.pdf |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
146 f. application/pdf |
dc.coverage.none.fl_str_mv |
São Paulo |
dc.publisher.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
publisher.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268321786232832 |